💡 Tip: There is a nice tutorial for UltraGrid by Jisc that can be used as a good starting point. You may also want to run other executables distributed with UltraGrid, like reflectors. This is ...

TTX-MC138 is delivered to glioblastoma tumors in murine models of the disease, following intravenous injection TTX-MC138 demonstrated suppression of miR-10b target and extended survival in aggressive ...

Video editing Mac users can efficiently produce professional-looking content on a MacBook Air thanks to iMovie's intuitive interface and the hardware acceleration of M-series chips. Beginners benefit ...

CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech ...

(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...

Abstract: Video transcoding in an adaptive bitrate streaming (ABR) system is demanded to support video streaming over heterogenous devices and varying networks. However, it could incur a tremendous ...

Transcode Therapeutics, Inc. (RNAZ) stock has reached a 52-week low, trading at $1.7, marking a significant downturn for the biotech company. With a market capitalization of just $1.25 million, ...

TransCode Therapeutics Inc. (NASDAQ:RNAZ) shares are moving higher Friday after the company announced that the first patient in Cohort 3 of its Phase 1 clinical trial has been dosed with its lead ...

TransCode Therapeutics (RNAZ) announced that it has received notice from the Nasdaq Stock Market that the company has regained compliance with Listing Rules 5550(a)(2) and 5550(b)(1), the Exchange’s ...

Transcode Therapeutics, Inc. (NASDAQ:RNAZ), a biopharmaceutical company, is confronting challenges with Nasdaq listing requirements, according to a recent SEC filing. The company, which specializes in ...

The trial aims to collect vital data on the safety of TTX-MC138 in patients with diverse metastatic solid cancers. Credit: RAGIB33/Shutterstock. TransCode Therapeutics has announced the commencement ...

TransCode Therapeutics shares are trading lower by 40.6% during Monday's session. The company disclosed plans for a potential reverse stock split in an open letter to its shareholders. Up Next: Get 5 ...